Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | KMO | O15229 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 3/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.54 |
| ▸ | DRD4 | P21917 | 2/20 | 0.54 |
| ▸ | DRD3 | P35462 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | PRCP | P42785 | 1/20 | 0.54 |
| ▸ | EBP | Q15125 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4959143 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL3356779 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL4961955 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL5272910 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL31123519 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1982025 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL219530 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL28703324 | 0.98 | HDAC4 (0.58) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1661863 | 0.98 | HDAC4 (0.61) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1658753 | 0.94 | HDAC4 (0.56) | HDAC4HDAC2HDAC8DRD2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015013456-A1 | INDICATOR COMPOUNDS, POLYMERIZABLE DERIVATIVES THEREOF AND INFECTION INDICATING MEDICAL DEVICES COMPRISING THE SAME | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2015-01-29 | — | — | WO | disclosed |
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| EP-1871844-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C Technologies LLC (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007008389-A2 | USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS | C2C TECHNOLOGIES LLC (US) | 2007-01-18 | — | — | WO | disclosed |
| US-20070010400-A1 | Use of color changing indicators in consumer products | C2C TECHNOLOGIES, LLC | 2007-01-11 | — | — | US | disclosed |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | CRAYOLA LLC | 2006-11-16 | — | — | US | disclosed |
| US-20060236470-A1 | Novelty compositions with color changing indicator | CRAYOLA LLC | 2006-10-26 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105191-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060222601-A1 | Oral care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-20060222675-A1 | Personal care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222675-A1 | Personal care compositions with color changing indicator | CUTA, POLR1C, TYR | HDAC4 1806/4885HDAC2 605/4885HDAC8 2052/4885 |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | WASHC5, WASHC4, FHIT | HDAC4 3947/4885HDAC2 4226/4885HDAC8 3601/4885 |
| US-20060222601-A1 | Oral care compositions with color changing indicator | CA9, CA7, TAS2R7 | HDAC4 558/4885HDAC2 451/4885HDAC8 838/4885 |
| US-20070010400-A1 | Use of color changing indicators in consumer products | NQO2, CA4, CA7 | HDAC4 559/4885HDAC2 1311/4885HDAC8 1409/4885 |
| US-20060236470-A1 | Novelty compositions with color changing indicator | MITF, CRABP2, SHH | HDAC4 1817/4885HDAC2 2140/4885HDAC8 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.